Navigation Links
LifeNet Health Chief Scientific Officer Wins Award
Date:5/8/2008

VIRGINIA BEACH, Va., May 8 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company announces that Lloyd Wolfinbarger, Jr., Ph.D., was awarded an Excellence in Innovation award at the 11th Annual Hampton Roads Technology Council's Tech Nite in Hampton, Virginia.

The Excellence in Innovation award, sponsored by Willcox and Savage, P.C., recognizes the most innovative patents that were filed from within the Hampton Roads region. Hampton Roads Technology Council considered approximately 170 patents and three winners were chosen out of 10 nominees. The awards were issued to Hampton Roads inventors that were deemed by a panel of experts to represent significant commercial potential and/or social benefit.

Dr. Wolfinbarger was awarded the Excellence in Innovation award for a patent on Bioreactor Mediated Recellularization of Natural and Tissue Engineered Vascular Grafts.

"We are honored to have Dr. Wolfinbarger leading our research efforts at LifeNet Health. His contributions to the tissue banking industry are helping to restore health to thousands of patients. Since LifeNet Health's beginning 25 years Dr. Wolfinbarger has played an integral part in our company's success. He is a leader in medicine and we're proud that the Hampton Roads Technology Council recognized his valuable contributions at Tech Nite," states Rony Thomas, LifeNet Health's CEO.

Tech Nite is an annual recognition event, organized by the Hampton Roads Technology Council, for high-tech companies, individuals, entrepreneurs, and innovations of the Hampton Roads region. The Hampton Roads Technology Council's (http://www.hrtc.org) mission is to accelerate the transformation of Hampton Roads and its technology firms into world-recognized technology leaders.

Dr. Wolfinbarger is the Chief Scientific Officer at LifeNet Health and his work has resulted in dozens of patents. He received his B.S. from Kansas State College of Pittsburg in 1966, a M.S. and Ph.D. in molecular genetics from Florida State University in 1969 and 1972. He joined the Old Dominion University faculty of the Department of Biological Sciences after post doctoral study.

Founded in 1982 and headquartered in Virginia Beach, Virginia, LifeNet Health, Inc., is a leading biomedical alloengineering organization and organ and tissue donation agency whose mission is saving lives and restoring health. LifeNet Health provides recovery and processing services for musculoskeletal and cardiovascular tissues, distributing more than 250,000 biomedical implants every year to restore health to patients around the world.

For more information about LifeNet Health then visit http://www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. LifeNet Health and IMS Announce Partnership
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
4. LifeNet Health(R) Unveils New Biomedical Spine Implant
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):